1) Diabetic renal microangipathy
糖尿病肾微血管病变
1.
Objective:To investigate the clinical significance of serum P-selection、TNF-a、hs-CRP in patients with Diabetic renal microangipathy, and the therapeutic mechanism of Simvastatin、Aspirinon.
目的:探讨糖尿病肾微血管病(Diabetic renal microangipathy,DN)患者血浆肿瘤坏死因子-a (tumor necrosis factor-a,TNF-a)、超敏C反应蛋白(Hypersen- sitivity C-Reactive Protein,hs-CRP)、P-选择素(P-selection)的临床意义及辛伐他汀、阿司匹林、辛伐他汀联合阿司匹林对糖尿病肾微血管病变患者的影响及可能的机制。
2) Diabeticmicrovascular complication
糖尿病微血管病变肾病
3) Diabetic microangiopathy
糖尿病微血管病变
1.
Experiment study on Erhuang Huoxue decoction in preventing and treating diabetic microangiopathy;
二黄活血汤防治糖尿病微血管病变的实验研究
2.
Relations between diabetic microangiopathy and endothelin and von Willebrand factor;
糖尿病微血管病变与血浆内皮素及血管性假血友病因子的关系
3.
Methods Fasting serum leptin (with RIA), insulin (with RIA) and fasting blood glucose (with oxidase method) levels were measured in 30 controls, 30 diabetic patients without microangiopathy and 30 patients with diabetic microangiopathy.
方法 :对照组、糖尿病无微血管病变组及糖尿病微血管病变组各 30例 ,其中糖尿病微血管病变组包括糖尿病肾病 2 5例 ,糖尿病视网膜病变 12例 ,同时合并DN与DR者 7例。
5) diabetic angiopathies
糖尿病血管病变
1.
Objective To explore the relationship between the changes levels of makers of thrombosis ( D-D、vWF、AT:A、PLG:A)and platelet membrance glycoprotein(CD62P、CD63) and Diabetic Angiopathies in Type Ⅱ diabetes patients.
目的探讨Ⅱ型糖尿病患者外周血中血栓标志物(D-二聚体D-D,血管性血友病因子(vWF),抗凝血酶活性AT:A,纤溶酶原活性PLG:A)水平变化和血小板活化状态标志物血小板α颗粒膜糖蛋白CD62P及溶酶体膜糖蛋白CD63的阳性表达率与糖尿病血管病变的关系。
6) Diabetic angiopathy
糖尿病血管病变
1.
Objective To probe into the mechanism of Di Dang Si Wu decoction in the treatment of diabetic angiopathy.
目的探讨抵当四五汤治疗糖尿病血管病变的作用机理。
2.
Objective To study the change of irritative immune molecules and factor about cell apoptosis and the relationship between these immune molecules and development of diabetic angiopathy and to provide academic basis for the prevention of diabetic vascular complications.
目的 从分子水平研究刺激性免疫分子和与细胞凋亡有关因子在糖尿病血管病变中的变化，探讨这些免疫分子之间以及这些免疫分子与糖尿病血管病变发生发展之间的相关性，为早期防治糖尿病血管并发症提供一定的理论依据。
3.
However, the pathogenesis of diabetic angiopathy is not fully known yet, inflammation and oxidative stress having been widely accepted to play an important role.
然而,目前糖尿病血管病变的发病机制尚不完全清楚,其中氧化应激和炎症损伤被广泛认为是重要的机制。
补充资料：糖尿
糖尿
glycosuria
特指葡萄糖尿。正常尿内可有微量葡萄糖，用一般定性方法不能测出。如尿内糖含量增高，用定性方法可以测出时则称为糖尿。其发生原因很多，按其形成机制分：①血糖增高性糖尿，指血中葡萄糖含量增高。同时尿糖排出增加，见于胰岛素分泌不足和生长激素、甲状腺素、肾上腺素、皮质醇等分泌增多，此外肝功能障碍，进食大量碳水化物也可出现糖尿；②血糖正常性糖尿，由于肾小管对葡萄糖的重吸收功能减退而引起的糖尿，又称肾性糖尿，见于家族性糖尿、慢性肾炎和肾病综合征时。其他糖尿，如乳糖、半乳糖、果糖、甘露醇等，当进食过多和体内代谢失调使血中浓度增高时，可出现相当的糖尿，假性糖尿，一些非糖物质如尿酸、维生素C、异烟肼等，在进行尿糖试验时，可具有还原性，尿糖试验呈阳性反应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条